836 related articles for article (PubMed ID: 26707044)
1. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers.
Maes M; Bosmans E; Kubera M
Neuro Endocrinol Lett; 2015; 36(5):439-46. PubMed ID: 26707044
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of autoimmune responses to oxidative specific epitopes, but not nitroso-adducts, is associated with a better clinical outcome in Myalgic Encephalomyelitis/chronic fatigue syndrome.
Maes M; Leunis JC
Neuro Endocrinol Lett; 2014; 35(7):577-85. PubMed ID: 25617880
[TBL] [Abstract][Full Text] [Related]
3. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
Maes M; Ringel K; Kubera M; Anderson G; Morris G; Galecki P; Geffard M
J Affect Disord; 2013 Sep; 150(2):223-30. PubMed ID: 23664637
[TBL] [Abstract][Full Text] [Related]
4. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.
Maes M; Twisk FN; Kubera M; Ringel K
J Affect Disord; 2012 Feb; 136(3):933-9. PubMed ID: 21975140
[TBL] [Abstract][Full Text] [Related]
5. Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome.
Maes M; Twisk FN; Kubera M; Ringel K; Leunis JC; Geffard M
J Affect Disord; 2012 Feb; 136(3):909-17. PubMed ID: 21967891
[TBL] [Abstract][Full Text] [Related]
6. A new case definition of Neuro-Inflammatory and Oxidative Fatigue (NIOF), a neuroprogressive disorder, formerly known as chronic fatigue syndrome or Myalgic Encephalomyelitis: results of multivariate pattern recognition methods and external validation by neuro-immune biomarkers.
Maes M
Neuro Endocrinol Lett; 2015; 36(4):320-9. PubMed ID: 26454487
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
Maes M; Twisk FN; Ringel K
Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
[TBL] [Abstract][Full Text] [Related]
8. Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS.
Maes M; Twisk FN
Neuro Endocrinol Lett; 2009; 30(6):677-93. PubMed ID: 20038921
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Wong N; Ramos S; Staines D; Marshall-Gradisnik S
BMC Immunol; 2015 Jun; 16():35. PubMed ID: 26032326
[TBL] [Abstract][Full Text] [Related]
10. Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.
Mensah F; Bansal A; Berkovitz S; Sharma A; Reddy V; Leandro MJ; Cambridge G
Clin Exp Immunol; 2016 May; 184(2):237-47. PubMed ID: 26646713
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome.
Maes M
Mod Trends Pharmacopsychiatry; 2013; 28():162-74. PubMed ID: 25224898
[TBL] [Abstract][Full Text] [Related]
12. Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: effects of age, duration of illness and the translocation of LPS from gram-negative bacteria.
Maes M; Leunis JC
Neuro Endocrinol Lett; 2008 Dec; 29(6):902-10. PubMed ID: 19112401
[TBL] [Abstract][Full Text] [Related]
13. The Reification of the Clinical Diagnosis of Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) as an Immune and Oxidative Stress Disorder: Construction of a Data-driven Nomothethic Network and Exposure of ME/CFS Subgroups.
Maes M; Kubera M; Stoyanova K; Leunis JC
Curr Top Med Chem; 2021 Oct; 21(16):1488-1499. PubMed ID: 34315375
[TBL] [Abstract][Full Text] [Related]
14. Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data.
Maes M; Twisk FN; Johnson C
Psychiatry Res; 2012 Dec; 200(2-3):754-60. PubMed ID: 22521895
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal analysis of immune abnormalities in varying severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Ramos S; Staines D; Marshall-Gradisnik S
J Transl Med; 2015 Sep; 13():299. PubMed ID: 26370228
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome.
Maes M; Leunis JC; Geffard M; Berk M
Neuro Endocrinol Lett; 2014; 35(6):445-53. PubMed ID: 25433843
[TBL] [Abstract][Full Text] [Related]
18. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
Liu Z; Cumberland WG; Hultin LE; Prince HE; Detels R; Giorgi JV
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):83-92. PubMed ID: 9358102
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways.
Morris G; Anderson G; Maes M
Mol Neurobiol; 2017 Nov; 54(9):6806-6819. PubMed ID: 27766535
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M
Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]